Effect of Genistein and Daidzein on Glucose Uptake in Isolated Rat Adipocytes; Comparison with Respective Glycones

  • Choi, Myung-Sook (Department of Food Science and Nutrition, Kyungpook National University) ;
  • Jung, Un-Ju (Department of Food Science and Nutrition, Kyungpook National University) ;
  • Kim, Myung-Joo (Department of Food Science and Nutrition, Daegu Polytechnic College) ;
  • Kim, Jong-Yeon (Department of Physiology, Yeungnam University School of Medicine) ;
  • Park, So-Young (Department of Physiology, Yeungnam University School of Medicine) ;
  • Jang, Joo-Yeum (Food and Bio-Industry Research Institute, Kyungpook National University) ;
  • Lee, Mi-Kyung (Food and Bio-Industry Research Institute, Kyungpook National University)
  • Published : 2005.03.01


Soy and soy foods are a rich source of isoflavones, which possess several biological activities. The effect of soy isoflavones, genistin and diadzin and their respective aglycones, on glucose uptake in adipocytes isolated from normal or high-fat fed rats was examined. As expected, insulin stimulated glucose uptake in a concentration-dependent manner. However, genistin and daidzin and their aglycones inhibited glucose uptake in a concentration-dependent (25-100μM) manner. In a time-course response, the aglycones significantly inhibited glucose uptake throughout 3 hr (after 30, 60, 120, 180 min), whereas the glycones only significantly inhibited the glucose uptake after 120 min and 180 min in the isolated rat adipocytes. Thus, the glucosides of genistein and daidzein, i.e. genistin and daidzin, were much less effective in inhibiting glucose uptake than their aglycones. In addition, genistin and daidzin did not significantly affect the insulin-stimulated glucose uptake, whereas genistein and daidzein did significantly inhibited glucose uptake compared to the vehicle control group by 47.5% and 24.8%, respectively (p < 0.05). The isoflavones also significantly inhibited glucose uptake in adipocytes isolated from rats fed a high-fat diet (50% of total calorie intake) when compared to the vehicle control. Finally, the isoflavones were found to enhance lipolysis in adipocytes isolated from high-fat fed rats, where the glycerol released by the aglycones was also higher than that released by the glycones. The current results showed that the inhibitory effect of daidzein on glucose uptake was very similar to that of genistein. The aglycones were more potent in inhibiting the uptake of glucose and a more potent stimulator of lypolysis than the glycones in adipocytes isolated from high-fat fed rats.


  1. Heinonen SM, Hoikkala A, Wahala K, Aldercreutz H. 2003. Metabolism of soy isoflavones daidzein, genistein and glycitein in human subjects. Identification of new metabolites having an intact isoflavonoid skeleton. J Steroid Biochem Mol Biol 87: 285-299
  2. Messina MJ, Persky V, Setchell KDR, Barnes S. 1994. Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr Cancer 21: 113-131
  3. Barnes S. 1998. Evolution of the health benefits of soy isoflavones. Proc Soc Exp Biol Med 217: 386-392
  4. Anthony MS, Clarkson TB, Williams JK. 1998. Effects of soy isoflavones on atherosclerosis: potential mechanism. Am J Clin Nutr 68: 1390S-1393S
  5. Hertog MG, Kromhout D, Aravanis C, Blackburn H, Buzine R, Fidanza F, Giampaoli, S, Jansen A, Menotti A, Nedeljkovic S. 1995. Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. Arch Int Med 155: 381-386
  6. Chang YC, Nair MG. 1995. Metabolism of daidzein and genistein by intestinal bacteria. J Nat Prod 58: 1892-1896
  7. Chang YC, Nair MG, Nitiss JL. 1995. Metabolites of daidzein and genistein and their biological activities. J Nat Prod 58: 1901-1905
  8. Hawksworth G, Drasar BS, Hill MJ. 1971. Intestinal bacteria and the hydrolysis of glycosidic bonds. J Med Microbiol 4: 451-459
  9. Xu X, Duncan AM, Merz BE, Kurzer MS. 1998. Effects of soy isoflavones on estrogen and phytoestrogen metabolism in premenopausal women. Cancer Epidemiol Biomarkers Prev 7: 1101-1108
  10. Rowland I, Faughnan M, Hoey L, Wahala K, Williamson G, Cassidy A. 2003. Bioavailability of phyto-oestrogens. Br J Nutr 89: S45-S58
  11. Jayagopal V, Albertazzi P, Kilpatrick ES, Howarth EM, Jenningburns PE, Hepburn DA, Atkin SL. 2002. Beneficial effects of soy phytoesterogen intake in postmenopausal women with type 2 diabetes. Diabetes Care 25: 1709-1714
  12. Bhathena SJ, Valasquez MT. 2002. Beneficial role of dietary phytoesterogens in obesity and diabetes. Am J Clin Nutr 76: 1191-1201
  13. Smith RM, Tiesinga JJ, Shah N, Smith JA, Jarett L. 1993. Genistein inhibits insulin-stimulated glucose transport and decrease immunocytochemical labeling of GLUT4 car-boxyl-terminus without affecting translocation of GLUT4 in isolated rat adipocytes: additional evidence of GLUT4 activation by insulin. Arch Biochem Biophys 300: 238-246
  14. Abler A, Smith JA, Randazzo PA, Rothenberg PL, Jarett L. 1992. Genistein differentially inhibits postreceptor effects of insulin in rat adipocytes without inhibiting the insulin receptor kinase. J Biol Chem 267: 3946-3951
  15. Nakashima S, Koike T, Nozawa Y. 1991. Genistein, a protein tyrosine kinase inhibitor, inhibits thromboxane $A_{2}$-mediated human platelet responses. Mol Pharmacol 39: 475-480
  16. Barnett M, Collier GR, Odea K. 1995. Energy intake with respect to the development of diabetes mellitus in psammomys obesus. Diabetes Nutr Metab 8: 42-47
  17. Riccardi G, Giacco R, Rivellese AA. 2004. Dietary fat, insulin sensitivity and the metabolic syndrome. Clin Nutr 23: 447-456
  18. Chalkley SM, Hettiarachchi M, Chisholm DJ, Kraege EW. 2002. Long-term high-fat feeding leads to severe insulin resistance but not diabetes in Wistar rats. Am J Physiol Endocrinol Metab 282: E1231-E1238
  19. Rodbell M. 1964. Metabolism of isolated fat cells; effects of hormones on glucose metabolism and lipolysis. J Biology Chem 239: 375-380
  20. Olefsky JM. 1978. Mechanisms of ability of insulin to activate the glucose-transport system in rat adipocytes. Biochem J 172: 137-145
  21. Vedavanam K, Srijayanta S, O'Reilly J, Raman A, Wiseman H. 1999. Antioxidant action and potential antidiabetic properties of an isoflavonoid-containing soyabean phytochemical extract (SPE). Phytother Res 13: 601-608<601::AID-PTR550>3.0.CO;2-O
  22. Baumann CA, Saltiel AR. 2003. Spatial compartmentalization of signal transduction in insulin action. Bioessays 23: 215-222<215::AID-BIES1031>3.0.CO;2-S
  23. Crofford OB, Renold AE. 1965. Glucose uptake by incubated rat epididymal adipose tissue. Characteristics of the glucose transport system and action of insulin. J Biol Chem 240: 3237-3244
  24. Simpson IA, Cushman SW. 1986. Hormonal regulation of mammalian glucose transport. Annu Rev Biochem 55: 1059-1089
  25. Kapiotis A, Hermann M, Held I, Seelos C, Ehringer H, Gemeiner BMK. 1997. Genistein, the dietary-derived angiogenesis inhibitor, prevents LDL oxidation and protects endothelial cells from damage by atherogenic LDL. Arterioscler Thromb Vasc Biol 17: 2868-2874
  26. Szkudelski T, Szkudelski K. 2000. Glucose as agent; studies on isolated rat adipocytes. Physiol Res 49: 213-217
  27. Szkudelska K, Nogowski L, Szkudelski T. 2000. Genistein affects lipogenesis and lipolysis in isolated rat adipocytes. J Steroid Biochem Mol Biol 75: 265-271
  28. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M, Fukami Y. 1987. Genistein, a specific inhibitor of tyrosine-specific protein kinase. J Biol Chem 262: 5592-5595
  29. Mezei O, Banz WJ, Steger RW, Peluso MR, Winters TA, Shay N. 2003. Soy isoflavones exert antidiabetic and hypolipidemic effects through the PPAR pathways in obese zucker rats and murine RAW 264.7 cells. J Nutr 133: 1238-1243
  30. Kim S, Shon I, Lee YS, Lee YS. 2005. Hepatic gene expression profiles are altered by genistein supplementation in mice with diet-induced obesity. J Nutr 135: 33-41